Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer

Immunotherapy has emerged as a promising modality for cancer treatment. Dendritic cell immunoreceptor (DCIR), a C-type lectin receptor, is expressed mainly by dendritic cells (DCs) and mediates inhibitory intracellular signaling. Inhibition of DCIR activation may enhance antitumor activity. DCIR is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Che-Yuan, Hung, Chi-Feng, Chen, Pi-Che, Hsu, Jia-Yu, Wang, Chung-Teng, Lai, Ming-Derg, Tsai, Yuh-Shyan, Shiau, Ai-Li, Shieh, Gia-Shing, Wu, Chao-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604824/
https://www.ncbi.nlm.nih.gov/pubmed/37892972
http://dx.doi.org/10.3390/biomedicines11102598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604824/
https://www.ncbi.nlm.nih.gov/pubmed/37892972
http://dx.doi.org/10.3390/biomedicines11102598

Ejemplares similares